Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
Abstract Background Neuromuscular blocking agent (NMBA) has been proposed by medical guidelines for early severe acute respiratory distress syndrome (ARDS) because of its survival benefits. However, new studies have provided evidence contradicting these results. Method A search was performed of the...
Main Authors: | An Thi Nhat Ho, Setu Patolia, Christophe Guervilly |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40560-020-0431-z |
Similar Items
-
Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials
by: Zhongjun Zheng, et al.
Published: (2020-01-01) -
Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
by: Wei Chang, et al.
Published: (2020-02-01) -
Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
by: Xue-biao Wei, et al.
Published: (2020-01-01) -
Neuromuscular blockade management in patients with COVID-19
by: Harold Chaves-Cardona, et al.
Published: (2021-08-01) -
COMPARATIVE ANALYSIS OF EFFICIENCY OF ACCELEROMYOGRAPHY AND KINEMYOGRAPHY TO MONITOR NEUROMUSCULAR TRANSMISSION
by: A. L. Lipnitsky, et al.
Published: (2017-11-01)